Feature Healthcare Stocks From $1 to $8? Why Analyst Experts Are Bullish on Cardiol Sometimes stock market performance doesn’t line up with the fundamentals of a… Robin LeffertsApril 1, 2025
Feature Healthcare Stocks Small Pharma, Big Gains: The Power of Clinical Trial Results For smaller pharmaceutical companies, valuation can be greatly impacted by progression in… Robin LeffertsMarch 13, 2025
Healthcare Stocks NeuroOne® Accelerates FDA Submission for Facial Pain Treatment NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) has announced an accelerated timeline for… Wilson AugustineMarch 11, 2025
Healthcare Stocks Light-Based Therapies Emerge as Promising Treatment for Parkinson’s Disease In a landscape dominated by traditional pharmaceuticals and invasive treatments, novel light-based… Robin LeffertsMarch 10, 2025
Healthcare Stocks Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug… Ryan AllwayFebruary 20, 2025
Feature Healthcare Stocks These Healthcare Stocks Significantly Outperformed the Industry in 2024 While the stock market broadly experienced significant gains in 2024, a few… Robin LeffertsJanuary 27, 2025
Healthcare Stocks Cardiol Execs and Board Members Increase Equity, Signal Confidence Members of the Cardiol Therapeutics Inc. (Nasdaq: CRDL) (TSX: CRDL) executive team… Robin LeffertsDecember 23, 2024
Healthcare Stocks Top News Ovation Science Licensee Launches Innovative Transdermal Cannabis Products in Pennsylvania VANCOUVER, BC / ACCESSWIRE / December 4, 2024 / (CSE:OVAT)(OTC PINK:OVATF) – Ovation… Ryan AllwayDecember 4, 2024
Feature Healthcare Stocks Top News Interview with Cardiol Therapeutics’ CEO David Elsley Cardiol Therapeutics Inc. (Nasdaq: CRDL) (TSX: CRDL) is a life sciences company… Robin LeffertsNovember 26, 2024
Feature Healthcare Stocks Cardiol’s Favorable Phase 2 Results Set the Table for Advanced Clinical Trials Cardiol Therapeutics Inc. (Nasdaq: CRDL) (TSX: CRDL) recently presented excellent results from… Robin LeffertsNovember 20, 2024